Patent Number: 9,250,243
Grant date: December 31, 1969
Priority date: September 21, 2006
Estimated expiration date: September 21, 2026
Inventor(s): Singh; Sharat (Los Altos Hills, CA), Harvey; Jeanne (Livermore, CA)
Assignee(s): NESTEC S.A. (Vevey, CH)
External link: USPTO website
The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.